Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Capvaxive by Quarter
Capvaxive (21-valent adult pneumococcal conjugate vaccine, launched Q2 2024) — Worldwide sales ($M) ($M)
Merck Capvaxive: $184M in Q2 2026, up 42.6% from a year earlier.
Where the Q2 2026 figure comes from
“|| Capvaxive | 142 | 184 | 325 | 107 | 129 | 236 | 244 | 279 | 759 | 42 | 40 | 38 | 36”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Segment & Product Sales Footnote & Form 8-K Table 3 / 3a / 3b.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Capvaxive (21-valent adult pneumococcal conjugate vaccine, launched Q2 2024) — Worldwide sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 184 | +42.6% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| Q1 2026 | Mar 31, 2026 | 142 | +32.7% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 279 | +458.0% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| Q3 2025 | Sep 30, 2025 | 244 | +151.5% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| Q2 2025 | Jun 30, 2025 | 129 | +158.0% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| Q1 2025 | Mar 31, 2025 | 107 | +127.7% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| Q4 2024 | Dec 31, 2024 | 50 | – | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q3 2024 | Sep 30, 2024 | 97 | – | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q2 2024 | Jun 30, 2024 | 50 | – | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q1 2024 | Mar 31, 2024 | 47 | – | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
Breakdown
What makes up capvaxive
Cite this data
StockData. (2026). Merck Capvaxive ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-capvaxive
See every metric in the Merck KPI table. Data updated Oct 26, 2026.